Monday - April 20, 2026

Category Archives: Marketing & Sales

Blood Pressure Monitoring Devices Market to Surpass USD 6 Billion by 2032, Growing at 10.01% CAGR Amid Rising Hypertension Burden and Digital Health Adoption | DelveInsight

Blood Pressure Monitoring Devices Market Key Companies in the Blood Pressure Monitoring Devices Market are Koninklijke Philips N.V., General Electric Company, A&D Company, Hill-Rom Services Inc., American Diagnostic Corporation, Withings, Spacelabs Healthcare, Braun Healthcare, GF HEALTH PRODUCTS INC, Microlife Corporation, … Continue reading →

Wilson’s Disease Market to Reach New Heights by 2034 with Advancing Gene Therapies and Strong Pipeline from Vivet Therapeutics, Pfizer, and Ultragenyx Pharmaceutical | DelveInsight

Wilson’s Disease Market Leading Wilson’s Disease companies, including Orphalan, AstraZeneca, Vivet Therapeutics, Pfizer,Ultragenyx Pharmaceutical, and others, are developing novel products to improve the Wilson’s Disease treatment outlook. DelveInsight’s “Wilson’s Disease Market Insights, Epidemiology, and Market Forecast – 2034” report provides … Continue reading →

Overt Hepatic Encephalopathy Market to Witness Steady Growth at a CAGR of 3.59% Through 2034, Driven by Rising Liver Disease Burden and Emerging Therapeutic Innovations | DelveInsight

Overt Hepatic Encephalopathy Market Overt Hepatic Encephalopathy market is poised for sustained growth over the next decade, fueled by increasing prevalence of chronic liver diseases, growing awareness, and advancements in treatment approaches. According to comprehensive market intelligence by DelveInsight, the … Continue reading →

Osteogenesis Imperfecta Market to Expand Significantly by 2034 with Advancements in Novel Therapies and Rising Disease Awareness, Reports DelveInsight

Osteogenesis Imperfecta Market Leading Osteogenesis Imperfecta companies operating in the market include Amgen, UCB, Ultragenyx Pharmaceuticals, Angitia, Sanofi, Mereo BioPharma, among others. The Osteogenesis Imperfecta (OI) market is expected to witness notable growth over the coming years, driven by increasing … Continue reading →

Hyperuricemia Clinical Trial Analysis 2026: 15+ Companies Advancing 20+ Therapies Across Clinical Stages, Driving Next-Gen Treatment Innovations | DelveInsight

Hyperuricemia Clinical Trial As per DelveInsight’s assessment, globally, Hyperuricemia pipeline constitutes 15+ key companies continuously working towards developing 20+ Hyperuricemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Hyperuricemia Pipeline Insight, … Continue reading →

Hypoglycemia Clinical Trials Surge as 15+ Companies Advance 20+ Therapies across Multiple Development Stages, analyses DelveInsight

Hypoglycemia Clinical Trials As per DelveInsight’s assessment, globally, Hypoglycemia pipeline constitutes 15+ key companies continuously working towards developing 20+ Hypoglycemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Hypoglycemia Pipeline Insight, … Continue reading →

HSV-1 Keratitis Pipeline Poised for Transformational Shift by 2026, Driven by Gene-Editing Innovations and Next-Generation Antiviral Strategies | DelveInsight

HSV-1 Keratitis Pipeline HSV-1 Keratitis Key companies working in the market are AiCuris Anti-infective Cures AG, Shanghai BDgene Co., Ltd, Excision BioTherapeutics, Inc, and others. “Hsv-1-Keratitis Pipeline Insight, 2026” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs … Continue reading →

Bread Loaf’s CEO Mark Milutin Breaks Down FDA Peptide Shift and What It Means for Telehealth

“This is telehealth’s 2012 e-commerce moment. Regulation, consumer demand, and technology are aligning at the same time — and the operators who move first aren’t just going to win, they’re going to define the category.” — Mark Milutin, Founder, Bread … Continue reading →

Neurostimulation Devices Market Projected to Reach USD 22.3 Billion by 2034: DelveInsight | Medtronic, Boston Scientific, and Abbott

Neurostimulation Devices Market Insights The leading companies in the neurostimulation devices landscape include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and LivaNova, which collectively held a market share of approximately 65-70% in 2024. These companies focus on innovation pipelines that … Continue reading →

Active Implantable Medical Devices Market Projected to Reach USD 44.9 Billion by 2032 with a 6.71% CAGR: DelveInsight | Medtronic, Abbott, and Cochlear Ltd.

Active Implantable Medical Devices Market Insights Leading companies operating in the active implantable medical devices market include Medtronic, Abbott, and Cochlear Ltd., all of which are actively pursuing technical innovations and strategic acquisitions to expand their market footprint. The global … Continue reading →